Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cocaine Use Disorder and Cortical Dopamine
NCT03349606Phase 1Completed
- Sponsor
- University of Pittsburgh
- Start
- Jun 2010
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by University of Pittsburgh. Primary endpoint: Percent change in Binding potential (BPnd) at 3 hours. Started Jun 2010; status: completed.
Beyond the preview
Go deeper on NCT03349606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349606.